N/A N=38 Prevention

Feeding and Wellness Among Late Preterm Infants

Late Preterm Infant

Bottom Line

View on ClinicalTrials.gov: NCT00470717 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2021

Primary outcome: Primary: Phone Call Completion Rate — 194; 102; 59; 52 calls

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Weekly telephone call (Procedure)
Age: Adult, Older Adult · 18+ yrs
Sex: Female
Sponsor: University Hospitals Cleveland Medical Center
Primary completion: Feb 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Phone Call Completion Rate	194; 102; 59; 52; 87	—

Summary

1. The first aim of this proposal is to pilot the feasibility of weekly phone monitoring of infant feeding and illness patterns in a socio-economically and racially diverse population. Specifically, the investigators aim to estimate the rate of group loss to follow up from birth to 13 weeks (3 months) of age with weekly phone interview of mothers of late preterm (LPT, gestational age 34 0/7- 36 6/7 weeks gestation) infants. 2. The second aim is to describe breastfeeding and formula feeding practices, and rates of illness and post-discharge hospital care utilization, through age 13 weeks (3 months) among late preterm infants born at MacDonald Women's Hospital. The investigators estimate that the rate of exclusive breastfeeding among LPT infants at 3 months of age is less than the documented rate of 37% for all infants in Cuyahoga County.

Eligibility Criteria

Inclusion Criteria

Mothers of singleton LPT (late preterm, gestational age 34 0/7- 36 6/7 completed weeks) infants

Exclusion Criteria

Exclusion criteria for mothers include positive maternal drug screen for drug of abuse
Age < 18 years, or per caregiver discretion mother is not appropriate for study.
Exclusion criteria for infants include custody under contention, positive screen for maternal drugs of abuse, or major congenital anomaly or congenital infection.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00470717). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.